Vanda Pharmaceuticals
Develops and commercializes specialty therapies across psychiatric, sleep, MS, and motion-sickness markets.
$5.29
After-hours close0.00 (0.00%)
At close$5.29(−2.76%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 83.70%50.33M sharesInsiders 9.10%5.47M sharesOther 7.20%4.33M shares
Shares outstanding 60.14M · Float 53.84M · 89.5% free float
Institutions13F, as of Jun 30, 2026
176 holders · 50.33M shares · 29 new positions · 97 increased · 55 reduced · 27 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 7.65M | 12.73% | +377.7K | Aug 7, 2026 |
| State Street Corp | 3.52M | 5.85% | +500.8K | Aug 7, 2026 |
| AQR Capital Management LLC | 3.50M | 5.82% | +1.89M | Aug 14, 2026 |
| Renaissance Technologies LLC | 3.44M | 5.72% | −318.2K | Aug 13, 2026 |
| Vanguard Capital Management LLC | 2.52M | 4.20% | +42.5K | Aug 13, 2026 |
| Aigh Capital Management LLC | 2.04M | 3.40% | −705.8K | Aug 7, 2026 |
| Acadian Asset Management LLC | 1.92M | 3.19% | +122.5K | Aug 13, 2026 |
| Dimensional Fund Advisors LP | 1.73M | 2.87% | −44.2K | Aug 11, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 8.10% | 4.70M | 13G | Feb 7, 2025 ↗ |
| Millennium Management LLC | 5.60% | 3.38M | 13G | Aug 19, 2026 ↗ |
| State Street Corporation | 5.10% | 3.02M | 13G | May 12, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Mihael Hristos Polymeropoulos | director, officer, other: President and CEO | 2.70M | 4.50% | Mar 4, 2026 |
| Gunther Birznieks | officer: SVP, Business Development | 494.2K | 0.82% | Mar 4, 2026 |
| Kevin Patrick Moran | officer: SVP, CFO & Treasurer | 411.4K | 0.68% | Mar 4, 2026 |
| Timothy Williams | officer: SVP & General Counsel | 377.5K | 0.63% | Mar 4, 2026 |
| Joakim Wijkstrom | officer: SVP, Chief Marketing Officer | 333.5K | 0.55% | Mar 4, 2026 |
| Richard W. Dugan | director | 219.1K | 0.36% | Jun 8, 2026 |
| Phaedra Chrousos | director | 165.0K | 0.27% | Jun 8, 2026 |
| Anne Sempowski Ward | director | 160.7K | 0.27% | Jun 8, 2026 |
| Tage Honore | director | 135.1K | 0.22% | Jun 8, 2026 |
| Christos Vasilios Mihael Polymeropoulos | officer: Senior VP, Medical Director | 129.8K | 0.22% | Apr 13, 2026 |
15 ten-percent owners hold 10.99M shares by Form 4, outside the officers-and-directors figure above · 17 people have not refiled in the last 18 months (2.53M shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Mar 2, 2026 | Gunther Birznieksofficer: SVP, Business Development | Sale | 42,431 | $8.27 | 494,197 |
| Mar 2, 2026 | Mihael Hristos Polymeropoulosdirector, officer, other: President and CEO | Sale | 156,235 | $8.17 | 2,704,496 |
| Mar 2, 2026 | Joakim Wijkstromofficer: SVP, Chief Marketing Officer | Sale | 30,800 | $8.27 | 333,469 |
| Mar 2, 2026 | Kevin Patrick Moranofficer: SVP, CFO & Treasurer | Sale | 42,442 | $8.27 | 411,380 |
| Mar 2, 2026 | Timothy Williamsofficer: SVP & General Counsel | Sale | 42,434 | $8.27 | 377,450 |
| Feb 23, 2026 | Tage Honoredirector | Sale | 30,000 | $8.03 | 93,469 |
CongressHouse and Senate disclosures
Not reported.